Teva Pharmaceutical Industries Limited (TEVA) is a publicly traded Healthcare sector company. As of October 3, 2026, TEVA trades at $39.27 with a market cap of $45.85B and a P/E ratio of 63.32. TEVA moved +0.56% today. Year to date, TEVA is +27.72%; over the trailing twelve months it is +97.16%. Its 52-week range spans $12.47 to $40.79. Analyst consensus is strong buy with an average price target of $45.00. Rallies surfaces TEVA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
TEVA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. TEVA recently traded at $39.27. Market cap is $45.85B. P/E ratio is 63.32. Revenue is $14.10B.
| Metric | Value |
|---|---|
| Price | $39.27 |
| Market Cap | $45.85B |
| P/E Ratio | 63.32 |
| EPS | $0.62 |
| Dividend Yield | 0.09% |
| 52-Week High | $40.79 |
| 52-Week Low | $12.47 |
| Volume | 4.23M |
| Avg Volume | 0 |
| Revenue (TTM) | $14.10B |
| Net Income | $709.00M |
| Gross Margin | 64.41% |
4 analysts cover TEVA: 0 strong buy, 4 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $45.00.